CASAMENTO CHARLES J

SEC Form 4 insider trading activity

CASAMENTO CHARLES J has filed 1 SEC Form 4 filing (9 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 10, 2026.

On the most recent filing, CASAMENTO CHARLES J is listed as Director at Eton Pharmaceuticals, Inc. Inside the rolling window, CASAMENTO CHARLES J reported no open-market purchases and 1 open-market sale totaling $5.3M in ETON.

Companies traded

Other insiders at ETON

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ETONSale$5.3MNov 10SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has CASAMENTO CHARLES J made?

CASAMENTO CHARLES J has filed 1 SEC Form 4 filing (9 transaction rows) across 1 company since 2026.

Which companies does CASAMENTO CHARLES J trade?

CASAMENTO CHARLES J has filed SEC Form 4 disclosures for 1 company, including ETON.

When was CASAMENTO CHARLES J's most recent SEC Form 4 filing?

CASAMENTO CHARLES J's most recent SEC Form 4 filing on Tracefour is dated Nov 10, 2026.

What is CASAMENTO CHARLES J's total buy and sell value in the current window?

Inside the rolling retention window, CASAMENTO CHARLES J bought $0 and sold $5.3M based on SEC Form 4 filings.

What was CASAMENTO CHARLES J's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 80,555 ETON shares on 2026-11-10, worth $5.3M, per SEC Form 4 filings.